NFE2L2 and neurodegenerative disease: In LPS-treated BV2 microglial cells, apigenin attenuated TNF-α, IL-1β, and IL-6 production by activating GSK3β/NRF2, suggested to be effective as a therapeutic agent against neurodegenerative diseases [78].